Tinea versicolor treated with terbinafine 1% solution

doi:10.1046/j.1365-4362.1999.00730.x

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

International Journal of Dermatology

Volume 38 Issue 11, Pages 863 - 865

Published Online: 25 Dec 2001

The Official Journal of the International Society of Dermatology

Go to Society Site

< Previous Abstract | Next Abstract >

Save Article to My Profile Download Citation Request Permissions

Abstract | References | Full Text: HTML, PDF (Size: 100K) | Related Articles | Citation Tracking

CLINICAL TRIAL

Tinea versicolor treated with terbinafine 1% solution

Ronald Savin MD, Drore Eisen MD, Mark S. Fradin MD and Mark Lebwohl MD

Savin Dermatology Center, New Haven, Connecticut, Dermatology Research Associates, Cincinnati, Ohio, Chapel Hill Dermatology, Chapel Hill, North Carolina, and Mt. Sinai Medical Center, New York, New York

Correspondence
Ronald Savin, MD
Savin Dermatology Center, PC
134 Park Street
New Haven
CT 06511
The Terbinafine Study Group (SF86−327)
Kimberly Butterwick, MD
Boni Elewski, MD
John Humeniuk, MD
Sewon Kang, MD
James Leyden, MD
Jonathan Weiss, MD
Michael Hall, MD
Susan Hilss
Thomas Lin, ph d
Presented in part at the 55th Annual Meeting of the American Academy of Dermatology, March 21–26, 1997, San Francisco, CA